TY - JOUR
T1 - Dual enzyme multi-layer bioreactors
T2 - Analytical modeling and experimental studies
AU - Segal, Vardit
AU - Lamed, Raphael
AU - Lotan, Noah
N1 - Funding Information:
This research was supported in part by grants fiom the Leonard and Diane Sherman Research Fund, from the Otto Meyerhof Biotechnology Laboratory established at the Technion by the Minerva Foundation, from the Archie Micay Biomedical Research Fund and from the Loewengart Research Fund. All are gratefully acknowledged. One of the authors (Vardit Segal) also acknowledges the support provided by the Marc and Louise Mitrani Memorial Fellowship and the Marjorie R. Oman, M.D. Memorial Fellowship.
PY - 1999
Y1 - 1999
N2 - Enzymic reactors are developed for a variety of biomedical-biotechnological applications, including blood detoxification. For the latter, an appropriate approach is to use enzymes of the Mercapturic Acid Pathway. The first two enzymes of this pathway are Glutathione-S-Transferase (GST) and γ-Glutamyl Transpeptidase (γGT). Earlier, the performance of an immobilized GST reactor was investigated experimentally and theoretically. Here, the analytical model was extended to describe a dual-enzyme continuous packed-bed reactor (DCP), in which the two enzymes (E1 and E2) are arranged in alternating layers. The performance of DCP reactors was first studied by numerical simulations, considering the effects of reactor configuration (i.e number of enzyme layers), kinetic characteristics (Km, Vmax, Kiq) and operational parameters (flow rate, substrates concentration). Results were obtained in terms of substrate and products concentration profiles along the reactor. The theoretical calculation were supplemented by experimental studies. In the latter GST (i.e. E1) and γGT (i.e. E2), were used when immobilized on porous beads, and the reactor was set up and operated in various configurations. It was found that the factors which mostly affect the performance of DCP systems are reactor configuration and extent of inhibition of E1 by its reaction product.
AB - Enzymic reactors are developed for a variety of biomedical-biotechnological applications, including blood detoxification. For the latter, an appropriate approach is to use enzymes of the Mercapturic Acid Pathway. The first two enzymes of this pathway are Glutathione-S-Transferase (GST) and γ-Glutamyl Transpeptidase (γGT). Earlier, the performance of an immobilized GST reactor was investigated experimentally and theoretically. Here, the analytical model was extended to describe a dual-enzyme continuous packed-bed reactor (DCP), in which the two enzymes (E1 and E2) are arranged in alternating layers. The performance of DCP reactors was first studied by numerical simulations, considering the effects of reactor configuration (i.e number of enzyme layers), kinetic characteristics (Km, Vmax, Kiq) and operational parameters (flow rate, substrates concentration). Results were obtained in terms of substrate and products concentration profiles along the reactor. The theoretical calculation were supplemented by experimental studies. In the latter GST (i.e. E1) and γGT (i.e. E2), were used when immobilized on porous beads, and the reactor was set up and operated in various configurations. It was found that the factors which mostly affect the performance of DCP systems are reactor configuration and extent of inhibition of E1 by its reaction product.
UR - http://www.scopus.com/inward/record.url?scp=0032764412&partnerID=8YFLogxK
U2 - 10.3109/10731199909117703
DO - 10.3109/10731199909117703
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0032764412
VL - 27
SP - 313
EP - 342
JO - Artificial Cells, Nanomedicine and Biotechnology
JF - Artificial Cells, Nanomedicine and Biotechnology
SN - 2169-1401
IS - 4
ER -